After Intuitive, Shockwave and Avail, Daniel Hawkins is now CEO at AI-powered MRI software startup Vista.ai

Former Avail Medsystems CEO Daniel Hawkins is now president and CEO of Vista.ai. [Photo courtesy of Avail Medsystems]Avail Medsystems founder and former CEO Daniel Hawkins has a new job as president and CEO of MRI software startup Vista.ai.

Palo Alto, California-based Vista.ai (founded and incorporated as HeartVista) makes AI-guided software for automating magnetic resonance imaging (MRI) exams.

Vista.ai was founded by Chief Medical Officer Bob Hu, Chief Architect and Head of Research Juan Santos and Chief Technology Officer William Overall. Its advisory board includes Stanford University doctors and professors and the radiology chair at the University of Wisconsin–Madison.

The company won FDA 510(k) clearances for its HeartVista Workstation with RTHawk application software for the acquisition of real-time and accelerated images from GE Healthcare whole-body MRI systems in 2014, 2017 and 2017. In 2019, the FDA cleared the company’s AI-assisted One Cli…

Read more
  • 0

FDA clears HeartVista’s MRI automation platform for Siemens Healthineers scanners

HeartVista announced today that it received FDA 510(k) clearance for its artificial intelligence-assisted One Click MRI acquisition software.

Palo Alto, California-based HeartVista’s One Click MRI software received the FD clearance for delivery on Siemens Healthineers’ MRI scanners. The company said in a news release that its AI-assisted solutions make cardiac magnetic resonance (CMR) exams on Siemens’ MRI scanners simpler, faster and capable of delivering more consistent results.

The company said its One Click MRI software includes product-wide speed and scan accuracy enhancements, along with new real-time automated analysis of regional wall motion as part of cardiac function assessment.

Additionally, the platform includes new registration of perfusion images for easier visual defect detection, enhanced T1-mapping for cardiomyopathy analysis and dedicated septal T1-mapping for myocarditis.

HeartVista initially won FDA 51…

Read more
  • 0